| Size | Price | Stock | Qty |
|---|---|---|---|
| 50mg |
|
||
| 100mg |
|
||
| 250mg |
|
||
| 500mg |
|
||
| 1g |
|
||
| 2g |
|
||
| 5g |
|
||
| Other Sizes |
|
Purity: ≥98%
Amfebutamone HCl (Bupropion, Wellbutrin, Zyban; BW-323; NSC315851; NSC-315851), the hydrochloride salt of Amfebutamone, is a potent and selective norepinephrine-dopamine reuptake inhibitor used as an antidepressant and for smoking cessation. It suppresses dopamine and norepinephrine reuptake with IC50s of 6.5 and 3.4 μM, respectively. One of the antidepressants that doctors prescribe the most in the US is amfebutamone.
| Targets |
Dopamine receptor; AChR
|
|---|---|
| ln Vitro |
Bupropion (Amfebutamone) hydrochloride inhibits CYP2D6 with an IC50 of 58 μM[1].
Bupropion hydrochloride, an atypical antidepressant, causes caspase-dependent cytotoxicity and endoplasmic reticulum stress in SH-SY5Y cells[3]. Bupropion hydrochloride causes apoptotic cell death in SH-SY5Y cells by inducing endoplasmic reticulum stress responses and activating JNK, which in turn activates caspase 3[3]. Bupropion (1-100 µg/mL) hydrochloride decreases the viability of cells. The decrease in cell viability caused by bupropion could have resulted from apoptotic processes[3]. Bupropion (100 μg/mL) hydrochloride increases GRP78 expression in less than a hour, as well as the phosphorylated forms of EIF-2α, JNK, and p38 MAPK[3]. |
| ln Vivo |
Bupropion (Amfebutamone) hydrochloride exhibits both anticonvulsant and convulsant properties in mice. In mice, bupropion induces clonic convulsions in a dose-dependent manner; the convulsive dose50 (or dose that produces convulsions in 50% of mice) is 119.7 mg/kg[4].
Bupropion hydrochloride dose-dependently reduces the immobility period (in seconds) in male albino mice weighing between 22 and 30 g (10, 15, 20, and 40 mg/kg, i.p.). This effect is observed in comparison to the vehicle control group. In the forced swim test and tail suspension test, bupropion's ED50 values for shortening the immobility period were determined to be 18.5 and 18 mg/kg i.p., respectively. In the mouse brain, bupropion hydrochloride (10, 20, and 40 mg/kg, i.p.) increases the concentration of free dopamine and its metabolite homovanillic acid in a dose-dependent manner[5]. |
| Cell Assay |
Cell Line: SH-SY5Y human catecholaminergic cells
Concentration: 0, 1, 10, 50, and 100 µg/mL Incubation Time: 24 hours Result: Cell viability decreased significantly in a concentration-dependent manner. |
| Animal Protocol |
Male Swiss mice weighing 20-25 g
100-160 mg/kg IP |
| References |
|
| Molecular Formula |
C13H19CL2NO
|
|
|---|---|---|
| Molecular Weight |
276.2
|
|
| Exact Mass |
239.11
|
|
| Elemental Analysis |
C, 56.53; H, 6.93; Cl, 25.67; N, 5.07; O, 5.79
|
|
| CAS # |
31677-93-7
|
|
| Related CAS # |
Bupropion morpholinol; 357399-43-0; Bupropion morpholinol-d6; 1216893-18-3; Bupropion; 34911-55-2; Bupropion hydrobromide; 905818-69-1
|
|
| Appearance |
Solid powder
|
|
| SMILES |
CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl
|
|
| InChi Key |
HEYVINCGKDONRU-UHFFFAOYSA-N
|
|
| InChi Code |
InChI=1S/C13H18ClNO.ClH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H
|
|
| Chemical Name |
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride
|
|
| Synonyms |
|
|
| HS Tariff Code |
2934.99.9001
|
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
|
|||
|---|---|---|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (9.05 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.05 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (9.05 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.6206 mL | 18.1028 mL | 36.2056 mL | |
| 5 mM | 0.7241 mL | 3.6206 mL | 7.2411 mL | |
| 10 mM | 0.3621 mL | 1.8103 mL | 3.6206 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
|
|
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
COA
